维普中文期刊产品整合服务
43篇 您的检索式:作者名="Mckinnon PS"
    题名 作者 年代 出处 被引量
1Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia显示文摘Lodise TP Mckinnon PS Swiderski L 2003Clin Infect Dis2003,36,:1
2Temporal assessment of candida risk factors in the surgical intensive care unit显示文摘 Goff DA Kern JW 2001Arch Surg2001,136,:1
3Temporal assessment of Candida risk factors in the surgical intensive care unit显示文摘McKinnon PS Goff DA Kern JW 2001Arch Surg2001,36,12:1
4Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases 显示文摘McKinnon PS Davis SL 2004Eur J Clin Microbiol Infect Dis2004,23,4:1
5Epidemiology,resistance,and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam显示文摘Jellison TK Mckinnon PS Rybak MJ 2001Pharmacotherapy2001,21,:1
6A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone 显示文摘Mohr JF Mckinnon PS Peymann PJ 2005Pharmaotherapy2005,25,10:1
7Outcomeassessment of minimizing vancomycin monitoring and dosingadjustments显示文摘Karam CM McKinnon PS Neuhauser MM 1999Pharmacotherapy1999,19,3:1
8Epidemiology, re sistanee,and outcomes of Acinetobacter baumannii bacte remia treated with imipenem-cilastatin or ampieillin-sul bactam显示文摘Jellison TK Mckinnon PS Rybak MJ 2001Pharmaeotherapy2001,21,2:1
9A retrospective,com- parative evaluation of dysglycemias in hospitalized patients re- ceiving gatifloxacin,levofloxacin,eiprofloxacin,or eefiTiaxone显示文摘Mohr JF McKinnon PS Peymann PJ 2005Pharmacotherapy2005,25,10:1
10Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections显示文摘McKinnon PS Paladino JA Schentag JJ 2008Int J Antimicrob Agents2008,31,4:1
11Epidemiology, risk factors, and outcomes of Candida albicans versu~ non-al- bicans candidemia in nonnentropenic patients显示文摘Davis SL Vazquez JA McKinnon PS 2007Ann Pharmacother2007,41,4:1
12A retrospective,comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin,levofloxacin,ciprofloxacin,or ceftriaxone显示文摘Mohr JF McKinnon PS Peymann PJ 2005Pharmacotherapy2005,25,:1
13Pharmaeokinetic and pharmacodynamie issues in the treatment of bacterial infectious diseases 显示文摘McKinnon PS Davis SL 2004Eur J Clin Microbiol Infect Dis2004,23,4:1
14Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration ( T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections显示文摘McKinnon PS Paladino JA Schentag JJ 2008Int J Antimicrob Agents2008,31,4:1
15Evaluation of area under the inhibitory curve ( AUIC ) and time above the minimum inhibitory concentration ( T>MIC ) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections显示文摘MCKINNON PS PALADINO JA SCHENTAG JJ 2008Int J Antimicrob Agents2008,31,4:1
16Temporal assessment of Candida risk factors in the surgical intensive care unit显示文摘McKinnon PS Goff DA Kern JW 2001Arch Surg2001,136,12:1
17Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia显示文摘Lodise TP McKinnon PS Swiderski L 2003Clin Infect Dis2003,36,11:1
18Epidemiology,resistance,and outcomes of Acinetobacter baumannii bacterenia treated with imipinem-cilastatin or ampicillin-sulbactam显示文摘Jellison TK Mckinnon PS Rybak MJ 2001Pharmacotherapy2001,21,2:1
19A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone 显示文摘Mohr JF Mckinnon PS Peymann PJ 2005Pharmacotherapy2005,25,:1
20Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia显示文摘Lodise TP McKinnon PS 2005Diagn Microbiol Infect Dis2005,52,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费